ID

26120

Description

Study ID: 111029 Clinical Study ID: 111029 Study Title: Double-blind, randomized study to evaluate the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 6 month schedule in healthy adult subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00289757 https://clinicaltrials.gov/ct2/show/NCT00289757 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A Documentation part: Visit 22, Long term Follow-Up, Year 17, Month 204 +/- 2 Months

Lien

https://clinicaltrials.gov/ct2/show/NCT00289757

Mots-clés

Versions (1)
  1. 09/10/2017 09/10/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

9 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine Visit 22 111029

Anglais

Visit 22 Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 111029

1 Formulaires  
Informed Consent
Description

Informed Consent

Alias
UMLS CUI-1
C0021430
UMLS CUI-2
C0170300
Subject Number
Description

Subject Number

Type de données

text

Alias
UMLS CUI [1]
C2348585
Center number
Description

Center number

Type de données

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Date of Visit
Description

Date of Visit

Type de données

date

Alias
UMLS CUI [1]
C1320303
Informed Consent Date
Description

I certify that Informed Consent has been obtained prior to any study procedure.

Type de données

time

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0011008
Demographics
Description

Demographics

Alias
UMLS CUI-1
C0011298
UMLS CUI-2
C0170300
Date of birth
Description

Date of birth

Type de données

date

Alias
UMLS CUI [1]
C0421451
Gender
Description

Gender

Type de données

text

Alias
UMLS CUI [1]
C0079399
Race
Description

Race

Type de données

text

Alias
UMLS CUI [1]
C0034510
Race, if other please specify
Description

Race

Type de données

text

Alias
UMLS CUI [1]
C0034510
Laboratory Tests
Description

Laboratory Tests

Alias
UMLS CUI-1
C0022885
UMLS CUI-2
C0005834
UMLS CUI-3
C0170300
Has a blood sample been taken?
Description

blood sample

Type de données

boolean

Alias
UMLS CUI [1]
C0005834
Has the subject received a dose of Hepatitis A immunoglobulins within 6 months prior to bleeding ?
Description

Hepatitis A immunoglobulins

Type de données

boolean

Alias
UMLS CUI [1,1]
C3652495
UMLS CUI [1,2]
C0019080
Has the subject received a dose of monovalent or combined Hepatitis A vaccine outside the study ?
Description

Hepatitis A vaccine

Type de données

boolean

Alias
UMLS CUI [1]
C0170300
Has the subject received a dose of monovalent or combined Hepatitis A vaccine outside the study ? If Yes, please specify
Description

Hepatitis vaccine

Type de données

integer

Alias
UMLS CUI [1,1]
C0170300
UMLS CUI [1,2]
C3543421
Did the subject suffer from Hepatitis A since last visit?
Description

Hepatitis A

Type de données

boolean

Alias
UMLS CUI [1]
C0019159
Retour au début de la page

Similar models

Visit 22 Immunogenicity and reactogenicity of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine 111029

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Informed Consent
C0021430 (UMLS CUI-1)
C0170300 (UMLS CUI-2)
Subject Number
Item
Subject Number
text
C2348585 (UMLS CUI [1])
Center number
Item
Center number
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Informed Consent Date
Item
Informed Consent Date
time
C0021430 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Demographics
C0011298 (UMLS CUI-1)
C0170300 (UMLS CUI-2)
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Gender
text
C0079399 (UMLS CUI [1])
Gender
Code List
Gender
CL Item
Male (M)
CL Item
Female (F)
Item
Race
text
C0034510 (UMLS CUI [1])
Race
Code List
Race
CL Item
White (WH)
CL Item
Black (BL)
CL Item
Oriental (OR)
CL Item
Other (OT)
Race
Item
Race, if other please specify
text
C0034510 (UMLS CUI [1])
Item Group
Laboratory Tests
C0022885 (UMLS CUI-1)
C0005834 (UMLS CUI-2)
C0170300 (UMLS CUI-3)
blood sample
Item
Has a blood sample been taken?
boolean
C0005834 (UMLS CUI [1])
Hepatitis A immunoglobulins
Item
Has the subject received a dose of Hepatitis A immunoglobulins within 6 months prior to bleeding ?
boolean
C3652495 (UMLS CUI [1,1])
C0019080 (UMLS CUI [1,2])
Hepatitis A vaccine
Item
Has the subject received a dose of monovalent or combined Hepatitis A vaccine outside the study ?
boolean
C0170300 (UMLS CUI [1])
Item
Has the subject received a dose of monovalent or combined Hepatitis A vaccine outside the study ? If Yes, please specify
integer
C0170300 (UMLS CUI [1,1])
C3543421 (UMLS CUI [1,2])
Hepatitis vaccine
Code List
Has the subject received a dose of monovalent or combined Hepatitis A vaccine outside the study ? If Yes, please specify
CL Item
Hepatitis A vaccine (1)
CL Item
Combined Hepatitis A (or other) vaccine (2)
Hepatitis A
Item
Did the subject suffer from Hepatitis A since last visit?
boolean
C0019159 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial